Cardio Diagnostics (CDIO) Competitors $4.15 -0.14 (-3.26%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$4.16 +0.01 (+0.24%) As of 07/11/2025 04:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CDIO vs. CARA, TENX, LSTA, CYTH, FBLG, KLTO, NNVC, BCAB, SNYR, and CMMBShould you be buying Cardio Diagnostics stock or one of its competitors? The main competitors of Cardio Diagnostics include Cara Therapeutics (CARA), Tenax Therapeutics (TENX), Lisata Therapeutics (LSTA), Cyclo Therapeutics (CYTH), FibroBiologics (FBLG), Klotho Neurosciences (KLTO), NanoViricides (NNVC), BioAtla (BCAB), Synergy CHC (SNYR), and Chemomab Therapeutics (CMMB). These companies are all part of the "pharmaceutical products" industry. Cardio Diagnostics vs. Its Competitors Cara Therapeutics Tenax Therapeutics Lisata Therapeutics Cyclo Therapeutics FibroBiologics Klotho Neurosciences NanoViricides BioAtla Synergy CHC Chemomab Therapeutics Cardio Diagnostics (NASDAQ:CDIO) and Cara Therapeutics (NASDAQ:CARA) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations. Does the media refer more to CDIO or CARA? In the previous week, Cardio Diagnostics had 5 more articles in the media than Cara Therapeutics. MarketBeat recorded 5 mentions for Cardio Diagnostics and 0 mentions for Cara Therapeutics. Cardio Diagnostics' average media sentiment score of 0.50 beat Cara Therapeutics' score of 0.00 indicating that Cardio Diagnostics is being referred to more favorably in the media. Company Overall Sentiment Cardio Diagnostics Neutral Cara Therapeutics Neutral Which has higher earnings & valuation, CDIO or CARA? Cardio Diagnostics has higher earnings, but lower revenue than Cara Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCardio Diagnostics$40K180.53-$8.38MN/AN/ACara Therapeutics$7.14M0.00-$118.51M-$21.01N/A Do analysts prefer CDIO or CARA? Cardio Diagnostics presently has a consensus price target of $60.00, suggesting a potential upside of 1,345.78%. Given Cardio Diagnostics' stronger consensus rating and higher probable upside, research analysts clearly believe Cardio Diagnostics is more favorable than Cara Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cardio Diagnostics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Cara Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is CDIO or CARA more profitable? Cara Therapeutics has a net margin of -1,099.76% compared to Cardio Diagnostics' net margin of -28,539.39%. Cardio Diagnostics' return on equity of -84.55% beat Cara Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Cardio Diagnostics-28,539.39% -84.55% -74.63% Cara Therapeutics -1,099.76%-367.97%-107.43% Do institutionals and insiders have more ownership in CDIO or CARA? 8.1% of Cardio Diagnostics shares are held by institutional investors. Comparatively, 44.7% of Cara Therapeutics shares are held by institutional investors. 22.3% of Cardio Diagnostics shares are held by company insiders. Comparatively, 3.1% of Cara Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has more volatility and risk, CDIO or CARA? Cardio Diagnostics has a beta of 2.96, meaning that its share price is 196% more volatile than the S&P 500. Comparatively, Cara Therapeutics has a beta of 0.41, meaning that its share price is 59% less volatile than the S&P 500. SummaryCardio Diagnostics beats Cara Therapeutics on 10 of the 13 factors compared between the two stocks. Get Cardio Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for CDIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CDIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CDIO vs. The Competition Export to ExcelMetricCardio DiagnosticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.46M$2.99B$5.61B$9.11BDividend YieldN/A2.39%5.24%4.02%P/E RatioN/A20.5827.9620.25Price / Sales180.53292.00430.8999.65Price / CashN/A42.8637.4658.16Price / Book0.587.638.045.49Net Income-$8.38M-$55.05M$3.18B$250.27M7 Day Performance8.64%8.54%3.67%4.80%1 Month Performance5.06%5.51%4.09%7.68%1 Year Performance-74.76%2.03%29.58%16.36% Cardio Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CDIOCardio Diagnostics3.1488 of 5 stars$4.15-3.3%$60.00+1,345.8%-74.8%$7.46M$40K0.001CARACara Therapeutics0.2949 of 5 starsN/AN/AN/A$24.33M$7.14M-0.2580Gap DownHigh Trading VolumeTENXTenax Therapeutics1.6539 of 5 stars$5.76-1.5%$17.50+203.8%+71.6%$24.27MN/A-2.329LSTALisata Therapeutics2.9634 of 5 stars$2.90+3.6%$15.00+417.2%-22.1%$24.12M$1M-1.2630Positive NewsCYTHCyclo TherapeuticsN/A$0.72flat$0.95+31.8%N/A$23.72M$870.73K-0.809FBLGFibroBiologics3.5438 of 5 stars$0.62+0.7%$13.00+1,989.4%-87.0%$23.65MN/A-2.9610News CoverageAnalyst ForecastGap UpKLTOKlotho NeurosciencesN/A$1.13+56.9%N/AN/A$23.40MN/A-3.14N/ANews CoverageGap DownHigh Trading VolumeNNVCNanoViricides0.3201 of 5 stars$1.40flatN/A-22.5%$22.50MN/A-1.9420Gap DownBCABBioAtla2.2107 of 5 stars$0.40+3.1%$5.00+1,162.6%-76.0%$22.43M$11M-0.3260SNYRSynergy CHC3.9778 of 5 stars$2.85+17.3%$10.00+250.9%N/A$22.34M$34.83M0.0040Gap UpHigh Trading VolumeCMMBChemomab Therapeutics2.7774 of 5 stars$1.16-0.9%$8.50+632.8%+1.4%$22.06MN/A-1.5320 Related Companies and Tools Related Companies CARA Competitors TENX Competitors LSTA Competitors CYTH Competitors FBLG Competitors KLTO Competitors NNVC Competitors BCAB Competitors SNYR Competitors CMMB Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CDIO) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardio Diagnostics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardio Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
